N

New England Cancer Specialists | Topsham, ME

Research site

(Unclaimed)

Location

105 Topsham Fair Mall Road Suite 1, Topsham, Maine, United States of America

Site insights

Top conditions

Top treatments

Sunitinib

Androgen

PF-08634404

Daraxonrasib

Avelumab

Axitinib

PF-06821497

RMC-6236

Enfortumab

Amivantamab

Parent organization

This site is a part of New England Cancer Specialists

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 7 total trials

A Study of Amivantamab and Olomorasib Combination Therapy in Participants With Metastatic Non-Small Cell Lung Cancer (KaRAnaSa)

The main purpose of this study is to find out the most suitable dose (recommended phase 2 combination dose \[RP2CD\]) of amivantamab and olomorasib c...

Enrolling

Carcinoma, Non-Small-Cell Lung

Drug: Amivantamab

Drug: Olomorasib

A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1).

Pfizer MEVPRO-1 (C2321014) is a randomized, open-label, multi-center clinical trial evaluating whether combining the study medicine (PF-06821497) wit...

Active, not recruiting

Metastatic Castrate Resistant Prostate Cancer (mCRPC)

Drug: PF-06821497

Drug: Enzalutamide

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

The purpose of this study is to learn more about a new medicine called PF-08634404, and how well it works in people with cancer of the colon or rectu...

Enrolling

Intestinal Neoplasms

Gastrointestinal Diseases

Biological: Bevacizumab

Drug: Chemotherapy